Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
80138.000.3725%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Molecular Partners AG

MOLNNASDAQ
Trade with Public
Trade with Public
$4.35
N/A
At close: Sep 4, 5:00 PM EST
$4.67
0.327.36%
After Hours: Aug 28, 4:43 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentCompareStock Report

Molecular Partners Analyst Price Targets

Wall Street analyst price targets and consensus rating for Molecular Partners (MOLN).

Price Target Range — 6 Quarters

Analyst Consensus — 3 Analysts

2Buy
1Hold
Consensus RatingBuy# Analysts3Avg. Consensus PT$10Upside to Avg. PT+105.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Apr 22, 2026HC Wainwright & Co.Robert BurnsMaintainedBuy$13
Mar 16, 2026HC Wainwright & Co.Robert BurnsMaintainedBuy$13
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Molecular Partners, Maintains $13 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Molecular Partners (NASDAQ:MOLN) with a Buy and maintains $13 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Molecular Partners, Maintains $13 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Molecular Partners (NASDAQ:MOLN) with a Buy and maintains $13 price target.
Benzinga Newsdesk

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

PRO
HC Wainwright & Co. Initiates Coverage On Molecular Partners with Buy Rating, Announces Price Target of $13

HC Wainwright & Co. analyst Robert Burns initiates coverage on Molecular Partners (NASDAQ:MOLN) with a Buy rating and announces Price Target of $13.
Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Molecular Partners, Lowers Price Target to $3.75

JP Morgan analyst Richard Vosser maintains Molecular Partners (NASDAQ:MOLN) with a Neutral and lowers the price target from $4 to $3.75.
Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Molecular Partners, Lowers Price Target to $4

JP Morgan analyst Richard Vosser maintains Molecular Partners (NASDAQ:MOLN) with a Neutral and lowers the price target from $4.5 to $4.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved